China Health Group Inc. (8225.HK)
HKD 0.19
(3.85%)
HKD 0.19
(3.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.12 Million | -5.15 Million | -10.27 Million | 19.11 Million | -485 Thousand | 2.85 Million |
| Net Income | -58.21 Million | -15.82 Million | 42.52 Million | 70.79 Million | 32.45 Million | 27.66 Million |
| Depreciation & Amortization | 234 Thousand | 151 Thousand | 201 Thousand | 291 Thousand | 1.27 Million | 1.04 Million |
| Deferred income taxes | - | - | -3.67 Million | - | - | -151 Thousand |
| Stock-based compensation | 511 Thousand | 2.13 Million | 572 Thousand | - | - | 220 Thousand |
| Change in working capital | -435 Thousand | 1.1 Million | -49.47 Million | -34.97 Million | -33.74 Million | -25.94 Million |
| Other non-cash items | -116 Thousand | 7.28 Million | -415 Thousand | -17 Million | -468 Thousand | 18 Thousand |
| Investing Cash Flow | -1.04 Million | -2.14 Million | 6.96 Million | -11.97 Million | 8000.00 | -1.54 Million |
| Investments in PPE | -6 Million | - | - | - | -1000.00 | -1.59 Million |
| Acquisitions | - | - | 33 Thousand | -47 Thousand | - | - |
| Investment purchases | - | -2.35 Million | - | -12.16 Million | - | - |
| Sales/Maturities of investments | 4.84 Million | - | - | - | - | - |
| Other Investing Activities | 4.96 Million | -2.14 Million | 6.93 Million | 234 Thousand | 9000.00 | 45 Thousand |
| Financing Cash Flow | - | - | -1.51 Million | 593 Thousand | -68 Thousand | 1.43 Million |
| Debt repayment | - | - | -1.5 Million | -1.5 Million | -1.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.04 Million | - | - |
| Other Financing Activities | - | - | -15 Thousand | 1.04 Million | 1.43 Million | 1.43 Million |
| Accounts receivables | 43.42 Million | 11.86 Million | -42.83 Million | -33.24 Million | -17.15 Million | -22.5 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 14.65 Million | -10.76 Million | -6.63 Million | -1.72 Million | -16.58 Million | -10.25 Million |
| Cash at beginning of period | 4.06 Million | 11.36 Million | 16.19 Million | 8.45 Million | 9 Million | 6.25 Million |
| Cash at end of period | 4.14 Million | 4.06 Million | 11.36 Million | 16.19 Million | 8.45 Million | 9 Million |
| Capital Expenditure | -6 Million | - | - | - | -1000.00 | -1.59 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 80 Thousand | -7.3 Million | -4.82 Million | 7.73 Million | -545 Thousand | 2.74 Million |
| Free Cash Flow | -4.88 Million | -5.15 Million | -10.27 Million | 19.11 Million | -486 Thousand | 1.26 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -58.21 Million | -63.94 Million | 108 Thousand | 4.93 Million | 891 Thousand | -15.82 Million |
| Depreciation & Amortization | 234 Thousand | - | - | - | - | 151 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 511 Thousand | 511 Thousand | - | - | - | 2.13 Million |
| Change in working capital | -435 Thousand | - | - | - | - | 1.1 Million |
| Other non-cash items | -116 Thousand | 63.43 Million | -108 Thousand | -4.93 Million | -891 Thousand | 7.28 Million |
| Investing Cash Flow | -1.04 Million | - | - | -554.16 Thousand | - | -2.14 Million |
| Investments in PPE | -6 Million | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -2.35 Million |
| Sales/Maturities of investments | 4.84 Million | - | - | - | - | - |
| Other Investing Activities | 4.96 Million | - | - | - | - | -2.14 Million |
| Financing Cash Flow | - | - | - | -226.19 Thousand | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 43.42 Million | - | - | - | - | 11.86 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 14.65 Million | - | - | - | - | -10.76 Million |
| Cash at beginning of period | 4.06 Million | - | - | 8.3 Million | - | 11.36 Million |
| Cash at end of period | 4.14 Million | - | - | 4.89 Million | - | 4.06 Million |
| Capital Expenditure | -6 Million | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | -3.95 Million | - | - |
| Net cash flow / Change in cash | 80 Thousand | - | - | -3.41 Million | - | -7.3 Million |
| Free Cash Flow | -4.88 Million | - | - | 1.31 Million | - | -5.15 Million |
MITQ
3196
BHK
LLFICL
ADVM
AFMD